Scarica l'app Stockscreener
22.15
5.93%
1.24
Dopo l'orario di chiusura:
22.42
0.27
+1.22%
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average - Zacks Investment Research
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo
Adma Biologics (ADMA) Moves 7.8% Higher: Will This Strength Last? - Yahoo Finance
Why ADMA Biologics Inc. (ADMA) Skyrocketed On Monday? - Insider Monkey
Biotech Stocks Dominate Monday’s Top 10 Gainers - Insider Monkey
Axogen and ADMA Biologics expect low to zero impact from recent tariffs - MSN
ADMA Biologics says tariffs will not impact operations due to fully U.S.-based supply chain - ROI-NJ
Does Adma Biologics (ADMA) Have the Potential to Rally 51.75% as Wall Street Analysts Expect? - MSN
ADMA Biologics Says Tariffs Not Likely to Impact Supply Chain, Production Operations - MarketScreener
Adma BiologicsTariffs Expected To Have No Impact On Adma's Operations - MarketScreener
ADMA Biologics Statement on Tariffs - GlobeNewswire
ADMA's All-American Operations Shield Company From New Tariff Storm - Stock Titan
Wall Street Analysts Predict a 39.08% Upside in Adma Biologics (ADMA): Here's What You Should Know - MSN
Trading (ADMA) With Integrated Risk Controls - news.stocktradersdaily.com
Ensign Group Invests in Growth With New Facility Acquisitions - TradingView
ADMA STOCK DROP ALERT: ADMA Biologics, Inc. Stock Drops over 20%; BFA Law Initiates Securities Fraud Investigation and Urges Investors with Losses to Contact the Firm (Nasdaq:ADMA) - ACCESS Newswire
What's Driving the Market Sentiment Around ADMA Biologics? - Benzinga
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? - Yahoo Finance
Adma Biologics (ADMA) Stock Moves -0.15%: What You Should Know - Yahoo Finance
How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback - MSN
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research
Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? - MSN
Adma Biologics CEO Adam Grossman sells $397,320 in stock By Investing.com - Investing.com Australia
Adma Biologics CEO Adam Grossman sells $397,320 in stock - Investing.com
Here is What to Know Beyond Why ADMA Biologics Inc (ADMA) is a Trending Stock - Yahoo Finance
ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential - Seeking Alpha
ADMA Stock Builds A Base As Profits Continue To Soar - MSN
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Pulse of the Market: Wednesday’s 10 Top Performers - Insider Monkey
Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus
Why ADMA Biologics Inc. (ADMA) Went Up On Wednesday? - Yahoo Finance
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - MSN
Will ADMA Biologics Stock Continue Its Momentum in 2025? - Yahoo Finance
Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views? - Yahoo Finance
Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Commit To Buy ADMA Biologics At $10, Earn 14% Using Options - Nasdaq
Bank of New York Mellon Corp Has $26.09 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Mutual of America Capital Management LLC Has $614,000 Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
0.98%
5.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):